Manotri Pharma Private Limited
About Manotri Pharma Private Limited
Data last updated:
Manotri Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 12 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2018PTC127598. Its GSTIN is 36AAGCN2521C1ZY (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Koteswara Rao Lingineni and Rajeswari Lingineni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 680 Srimaan Residency Road No 15 Vasanth Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.78 Lakh. For the same year it recorded a net profit of ₹24,941 (net margin 5.2%) and EBITDA of ₹1.04 Lakh (EBITDA margin 21.7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.
Company details
Contact details
Manotri Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 680 Srimaan Residency Road No 15 Vasanth Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Manotri Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Manotri Pharma Private Limited
FY 2025 filings availableManotri Pharma Private Limited reported revenue of ₹4.78 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over three years. EBITDA rose 576% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,941 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.7% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manotri Pharma Private Limited, buy the company report.
Board of directors of Manotri Pharma Private Limited
Manotri Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koteswara Rao Lingineni | Director | 12 Oct 2018 | 8 Years 0 Months | Current |
| Rajeswari Lingineni | Director | 12 Oct 2018 | 8 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Manotri Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manotri Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manotri Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCN2521C1ZY | Telangana | Active | 19 Dec 2018 |
To see the full GST registrations and return filing status of Manotri Pharma Private Limited, buy the company report.
Recent activity
Manotri Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Devina Gupta ceased to be Director on 27 Jan 2020.
Frequently asked questions
Manotri Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 12 October 2018 (8+ years old) and is registered under CIN U24304TG2018PTC127598.
Manotri Pharma has 2 current directors:
- Koteswara Rao Lingineni - Director
- Rajeswari Lingineni - Director
The latest financial statements of Manotri Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Manotri Pharma is 36AAGCN2521C1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Manotri Pharma is U24304TG2018PTC127598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manotri Pharma was incorporated on 12 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Devina Gupta ceased to be Director on 27 Jan 2020. Koteswara Rao Lingineni was appointed as Director on 12 Oct 2018. Rajeswari Lingineni was appointed as Director on 12 Oct 2018.
The registered office of Manotri Pharma is at Plot No 680 Srimaan Residency Road No 15 Vasanth Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Manotri Pharma operates in the food and beverages industry, in the manufacturing segment.
Manotri Pharma can be reached at its registered office: Plot No 680 Srimaan Residency Road No 15 Vasanth Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
